Interaction of Vascular Damage and Alzheimer Dementia: Focal Damage and Disconnection

References

• 1. Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 2016;15(5):455–532.
  MedlineGoogle Scholar
• 2. Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27(4):685–691.
  MedlineGoogle Scholar
• 3. Saito S, Ihara M. Interaction between cerebrovascular disease and Alzheimer pathology. Curr Opin Psychiatry 2016;29(2):168–173.
  MedlineGoogle Scholar
• 4. Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011;10(9):698–712.
  MedlineGoogle Scholar
• 5. Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci 2015;18(6):794–799.
  MedlineGoogle Scholar
• 6. Scheltens P, Blennow K, Breteler MM, et al. Alzheimer’s disease. Lancet 2016 Feb 23. [Epub ahead of print]
  Google Scholar
• 7. Lee S, Viqar F, Zimmerman ME, et al. White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 2016;79(6):929–939.
  MedlineGoogle Scholar
• 8. Guzman VA, Carmichael OT, Schwarz C, et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Alzheimers Dement 2013;9(5 Suppl):S124–S131.
  MedlineGoogle Scholar
• 9. De Reuck J, Deramecourt V, Cordonnier C, et al. The incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia. J Neurol Sci 2016;366:164–166.
  MedlineGoogle Scholar
• 10. Gutierrez J, Honig L, Elkind MS, et al. Brain arterial aging and its relationship to Alzheimer dementia. Neurology 2016;86(16):1507–1515.
  MedlineGoogle Scholar
• 11. Madigan JB, Wilcock DM, Hainsworth AH. Vascular contributions to cognitive impairment and dementia: topical review of animal models. Stroke 2016;47(7):1953–1959.
  MedlineGoogle Scholar
• 12. Brickman AM. Contemplating Alzheimer’s disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep 2013;13(12):415.
  MedlineGoogle Scholar
• 13. Mortamais M, Artero S, Ritchie K. White matter hyperintensities as early and independent predictors of Alzheimer’s disease risk. J Alzheimers Dis 2014;42(Suppl 4):S393–S400.
  MedlineGoogle Scholar
• 14. Kapasi A, Schneider JA. Vascular contributions to cognitive impairment, clinical Alzheimer’s disease, and dementia in older persons. Biochim Biophys Acta 2016;1862(5):878–886.
  MedlineGoogle Scholar
• 15. Schiemanck SK, Kwakkel G, Post MW, Prevo AJ. Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: a critical review of the literature. Neurorehabil Neural Repair 2006;20(4):492–502.
  MedlineGoogle Scholar
• 16. Vernooij MW, Ikram MA, Vrooman HA, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009;66(5):545–553.
  MedlineGoogle Scholar
• 17. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987;149(2):351–356.
  MedlineGoogle Scholar
• 18. Scheltens P, Barkhof F, Leys D, et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114(1):7–12.
  MedlineGoogle Scholar
• 19. Inzitari D, Simoni M, Pracucci G, et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007;167(1):81–88.
  MedlineGoogle Scholar
• 20. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
  MedlineGoogle Scholar
• 21. Haller S, Kövari E, Herrmann FR, et al. Do brain T2/FLAIR white matter hyperintensities correspond to myelin loss in normal aging? A radiologic-neuropathologic correlation study. Acta Neuropathol Commun 2013;1:14.
  MedlineGoogle Scholar
• 22. Debette S, Bombois S, Bruandet A, et al. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007;38(11):2924–2930.
  MedlineGoogle Scholar
• 23. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000;57(11):1071–1076.
  MedlineGoogle Scholar
• 24. Gouw AA1, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011 Feb;82(2):126–135.
  MedlineGoogle Scholar
• 25. Jokinen H, Schmidt R, Ropele S, et al. Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol 2013;73(5):576–583.
  MedlineGoogle Scholar
• 26. van Norden AG, de Laat KF, van Dijk EJ, et al. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. Biochim Biophys Acta 2012;1822(3):401–407.
  MedlineGoogle Scholar
• 27. Meng D, Hosseini AA, Simpson RJ, et al. Lesion topography and microscopic white matter tract damage contribute to cognitive impairment in symptomatic carotid artery disease. Radiology 2016;282(2):502–515.
  Google Scholar
• 28. Bennett IJ, Madden DJ. Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience 2014;276:187–205.
  MedlineGoogle Scholar